Part 6/7:
A notable point of discussion involves the recent U.S. demand that American drug companies guarantee U.S. prices, which could influence negotiations around pharmaceuticals. Australian officials reassured that their health system, particularly the Pharmaceutical Benefits Scheme (PBS), remains protected, and drug prices for Australians are unlikely to be impacted adversely.
At present, there have been no updates regarding this issue from the U.S. administration, but Australia remains committed to safeguarding its healthcare system from potential external pressures.